Interview with the President and CEO – Cancer Genetics, Inc. (NASDAQ:CGIX)
John A. (Jay) Roberts is the Chief Executive Officer, President, Principal Financial Officer and Principal Accounting Officer of Cancer Genetics, Inc. (CGI). Mr. Roberts brings significant vision and operational and financial experience to CGI with a strong track record of disciplined growth, operational excellence, and shareholder value creation in multiple public and private equity-backed health care technology and service companies, including InfoLogix, AdvantEdge Healthcare Solutions, Clarient and, most recently, VirMedica. His professional background includes a deep understanding of clinical and health care billing, diagnostics, clinical operations, and health care-focused IT. In addition, Mr. Roberts is a longstanding board member, recent chairman and currently the chairman of the Fellows for the Drug Information Association (DIA), a neutral, global nonprofit association focused on advancing health care product development around the world by connecting stakeholders to interdisciplinary insights and innovation. Mr. Roberts has a Master of Business Administration and Bachelor of Science from the University of Maine. He has served as a recognized thought leader and expert panelist for numerous publications and programs related to mergers and acquisitions and corporate finance in the health care industry. Profile
Word count: 3,058
TWST: Let’s start with a brief history and introduction to Cancer Genetics.
Mr. Roberts: Cancer Genetics was founded in 1999. At that time,